Who backs AltruBio?
10 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Blackstone | — |
| Cormorant Asset Management | Venture capital |
| Soleus Capital | PE / buyout |
| CAM Capital | Family office |
| BVF Partners | — |
| Delos Capital Partners | — |
| EVX Ventures | — |
| T1D Fund | — |
| aMoon Fund | — |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
AltruBio investors
10 investors are on record for AltruBio, including RA Capital Management, Blackstone, Cormorant Asset Management and Soleus Capital. The Series B in May 2024 drew 7 investors.
Free account
More of AltruBio with a free account
- ·Watch AltruBio: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 10 firms already write checks for companies like AltruBio in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View